Oh damn, this will be the coming Wed, in 3 more sleeps.
Merck is talking to Australia directly with licensing/partnering activities. Tell me there is nothing to do with eftilagimod.
And look at the reply in below, directly from their licensing team from the oncology branch.
Media, page-711
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
0.005(1.06%) |
Mkt cap ! $567.6M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.5¢ | 47.3¢ | $903.5K | 1.887M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 21085 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 163273 | 15 |
View Market Depth
| Last trade - 15.33pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
47.5¢ |
Change
0.005 ( 1.15 %) |
||||
| Open | High | Low | Volume | ||
| 48.0¢ | 48.5¢ | 47.0¢ | 641769 | ||
| Last updated 15.48pm 22/05/2024 ? | |||||
| IMM (ASX) Chart |